Bio X Cell, LLC (“BXC” or the “Company”), the world’s leading producer of monoclonal antibodies for pre-clinical in vivo research applications, is pleased to announce the appointments of Alan Hirzel and Kevin Ballinger to its Board of Directors.
Bio X Cell, LLC (“BXC” or the “Company”), the world’s leading producer of monoclonal antibodies for pre-clinical in vivo research applications, is pleased to announce the appointments of Alan Hirzel and Kevin Ballinger to its Board of Directors.
Designed by doctors. Powered by AI.
Owned by you.